{"meta":{"query_hash":"416724d61cad","filters":{"venue":"Drug Target Insights"},"cohort_total":10,"direct_labels_cover":0,"predictions_cover":10,"exported":10,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/416724d61cad","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+Target+Insights"},"results":[{"id":"W1496935185","doi":"10.4137/dti.s447","title":"Therapies to Increase ApoA-I and HDL-Cholesterol Levels","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Reverse cholesterol transport; Cholesterol; Medicine; Internal medicine; Endocrinology; Lipoprotein; High-density lipoprotein; Excretion; Endogeny","score_opus":0.019949095845854983,"score_gpt":0.2353904733805925,"score_spread":0.21544137753473752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1496935185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2519354,0.57438666,0.025470918,0.037005197,0.005174653,0.00072569324,0.0010120552,0.0010980666,0.10319137],"genre_scores_gemma":[0.6175582,0.2932138,0.033222117,0.012549225,0.0037941353,0.00095397973,0.000768632,0.00006118623,0.037878647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998505,0.00004018251,0.000009831383,0.000016701799,0.000063613115,0.00001910797],"domain_scores_gemma":[0.9998809,0.000036434183,0.000032005504,0.000009264964,0.000022058783,0.000019251223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029597405,0.0003239046,0.0004162079,0.00062455627,0.00019935337,0.00037281573,0.00027803282,0.0007757032,0.005055365],"category_scores_gemma":[0.0005919241,0.00007748082,0.00025429844,0.00026005178,0.0002618341,0.00031959853,0.00026956422,0.0013069946,0.0012163376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024031904,0.0025896614,0.002573782,0.0034376348,0.0002239709,0.0008309015,0.00016632013,0.00045150737,0.11329271,0.015673872,0.031906072,0.82645035],"study_design_scores_gemma":[0.00419428,0.009120315,0.019436896,0.0013574185,0.0006228272,0.0056345183,0.00031124722,0.0015790835,0.084871635,0.017661639,0.85515404,0.000056092304],"about_ca_topic_score_codex":0.00027187218,"about_ca_topic_score_gemma":0.00046126827,"teacher_disagreement_score":0.005055365,"about_ca_system_score_codex":0.00029888368,"about_ca_system_score_gemma":0.00033952555,"threshold_uncertainty_score":0.016911864},"labels":[],"label_agreement":null},{"id":"W1546961109","doi":"10.4137/dti.s378","title":"Recent Advancements in Targeted Delivery of Therapeutic Molecules in Neurodegenerative Disease–-Spinocerebellar Ataxia–-Opportunities and Challenges","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Faculty of Medicine, McGill University; McGill University","keywords":"Medicine; Spinocerebellar ataxia; Disease; Gene silencing; Bioinformatics; Genetic enhancement; Ataxia; Drug discovery; Nanocarriers; Computational biology; Drug; Neuroscience; Gene; Biology; Pharmacology; Genetics; Pathology; Psychiatry","score_opus":0.04820452856902558,"score_gpt":0.23936255618856658,"score_spread":0.191158027619541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546961109","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013599803,0.95605856,0.017290128,0.004334129,0.00070738344,0.000025051928,0.000052271196,0.00011865818,0.007814035],"genre_scores_gemma":[0.045925505,0.9342711,0.011935334,0.0011352913,0.00105199,0.000037778747,0.00011537255,0.000023221954,0.005504466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997211,0.000062698906,0.000030970794,0.000057459205,0.00009383764,0.000033915192],"domain_scores_gemma":[0.9992211,0.00040993965,0.000086590895,0.000035474965,0.00018013202,0.00006675114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010424779,0.0003881225,0.0006460118,0.0006192807,0.00023482552,0.00077568734,0.0004971943,0.00093068084,0.0029797775],"category_scores_gemma":[0.0007946543,0.00019884061,0.0003316591,0.00085866865,0.00051071314,0.001281402,0.00041577272,0.0011701086,0.0012651586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003395655,0.00019012092,0.00079500553,0.0067009674,0.000058459445,0.0004981408,0.00032261768,0.0017543472,0.12290141,0.02183688,0.009635283,0.83496726],"study_design_scores_gemma":[0.000052378236,0.0010515855,0.0036484848,0.0007357434,0.00022389634,0.0044277883,0.0004515838,0.0041882377,0.10478736,0.012629489,0.86772877,0.000074660624],"about_ca_topic_score_codex":0.0003762374,"about_ca_topic_score_gemma":0.0005600434,"teacher_disagreement_score":0.0029797775,"about_ca_system_score_codex":0.00046219694,"about_ca_system_score_gemma":0.0006765682,"threshold_uncertainty_score":0.0099684},"labels":[],"label_agreement":null},{"id":"W1759449679","doi":"10.4137/dti.s1146","title":"A Model for NAD(P)H: Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy","year":2009,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation; Welch Foundation","keywords":"Cancer research; Chemotherapy; Benzoquinone; NAD+ kinase; Medicine; Bone marrow; Pharmacology; Chemistry; Enzyme; Biochemistry; Immunology; Internal medicine","score_opus":0.12457566101711524,"score_gpt":0.43092028224312057,"score_spread":0.3063446212260053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1759449679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7776367,0.0034030923,0.20854224,0.0011693413,0.00019467695,0.00017967178,0.00027787272,0.0001923335,0.008404155],"genre_scores_gemma":[0.9518345,0.002510785,0.038249947,0.0001943122,0.000028538503,0.0001547693,0.00022461705,0.000027266711,0.006775132],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999366,0.000010884449,0.0000020373056,0.000020597694,0.00001999701,0.000009863155],"domain_scores_gemma":[0.999969,0.000008522161,0.000008887034,0.0000032642633,0.000004205038,0.0000060919715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073639705,0.00024662758,0.0003022948,0.00011143845,0.0001569415,0.00018592327,0.00038009393,0.00034554017,0.0009436201],"category_scores_gemma":[0.00009802805,0.00011462877,0.00025789894,0.00011046309,0.00025119112,0.00035806574,0.00018733833,0.0005060129,0.00024575507],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076524506,0.0000683755,0.00015788134,0.0000749309,0.000010434468,0.00012443135,0.00002957438,0.014462357,0.97279674,0.008916435,0.00024283539,0.0030395938],"study_design_scores_gemma":[0.00015560057,0.0026244891,0.00089163,0.000019056897,0.000072585055,0.0005578486,0.000058789017,0.23996235,0.7215826,0.009114796,0.02491615,0.000044126533],"about_ca_topic_score_codex":0.0006654302,"about_ca_topic_score_gemma":0.000774579,"teacher_disagreement_score":0.0009436201,"about_ca_system_score_codex":0.00036632683,"about_ca_system_score_gemma":0.0002553609,"threshold_uncertainty_score":0.0031567812},"labels":[],"label_agreement":null},{"id":"W2277636392","doi":"10.4137/dti.s9442","title":"Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent","year":2012,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Resveratrol; Neuroinflammation; Angiogenesis; Matrix metalloproteinase; Inflammation; Cancer research; Gene silencing; Pharmacology; Blood–brain barrier; Medicine; Chemistry; Biology; Immunology; Central nervous system; Internal medicine; Biochemistry; Gene","score_opus":0.011675455683288547,"score_gpt":0.24532722704263693,"score_spread":0.2336517713593484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277636392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867849,0.0055917506,0.003561319,0.0003256767,0.000115751216,0.000049744394,0.0009088697,0.00014642737,0.0025155954],"genre_scores_gemma":[0.99013805,0.0031487471,0.0018677828,0.00013646438,0.00002536403,0.000048925802,0.0012671485,0.000021965145,0.0033455626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998858,0.000017649063,0.000009053528,0.000026277072,0.00003083566,0.000030326055],"domain_scores_gemma":[0.9999324,0.000009519674,0.000019390412,0.000008444748,0.00001562988,0.000014623675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010109647,0.00035900448,0.00031300468,0.00019860908,0.000107238964,0.00022065095,0.00013144565,0.00021757244,0.0012413249],"category_scores_gemma":[0.000091634574,0.00013972918,0.00042748146,0.00010830684,0.00019722526,0.000162137,0.00010795955,0.00063901814,0.00032474188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018526876,0.000029067463,0.00011660731,0.00007469803,0.000011858879,0.000019929688,0.000009318568,0.000025936804,0.9983052,0.000046327306,0.000051545696,0.0011241722],"study_design_scores_gemma":[0.000026278003,0.0005217654,0.0068772743,0.000007655755,0.00005547509,0.00014781117,0.000028753047,0.0003410083,0.9889148,0.00004775989,0.0030263108,0.0000051734733],"about_ca_topic_score_codex":0.0004409489,"about_ca_topic_score_gemma":0.0012333808,"teacher_disagreement_score":0.0012413249,"about_ca_system_score_codex":0.00017489969,"about_ca_system_score_gemma":0.00020743444,"threshold_uncertainty_score":0.0041526556},"labels":[],"label_agreement":null},{"id":"W3215818202","doi":"10.33393/dti.2021.2347","title":"Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury","year":2021,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"European Society of Intensive Care Medicine; Ministero dell’Istruzione, dell’Università e della Ricerca; Società Italiana Anestesia, Analgesia, Rianimazione e Terapia Intensiva","keywords":"Medicine; ARDS; Bronchoalveolar lavage; Lung; Inflammation; Pulmonary fibrosis; Fibrosis; Pulmonary compliance; Pathology; Internal medicine","score_opus":0.006968065066650779,"score_gpt":0.24400300859119448,"score_spread":0.23703494352454368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215818202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892237,0.007639656,0.0012458884,0.00020326469,0.00007693229,0.00006206191,0.0003746262,0.00008327143,0.001090671],"genre_scores_gemma":[0.99155605,0.0048392806,0.00094894826,0.00015518407,0.000046827732,0.000054234206,0.00038422327,0.000007953508,0.0020071848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991584,0.00001682935,0.000007122265,0.000012337157,0.000023594846,0.000024279048],"domain_scores_gemma":[0.9999205,0.0000059954777,0.00003256287,0.0000045561537,0.000007662134,0.000028842585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014011623,0.00036833723,0.00027824816,0.0002162119,0.00010551959,0.0002147417,0.000164955,0.00027358002,0.0016228541],"category_scores_gemma":[0.00007109956,0.00008982869,0.00023217556,0.00012696008,0.00020856448,0.00021578558,0.00013278883,0.00065423694,0.00016260844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030398397,0.00040110308,0.0009651744,0.00020471802,0.00002801986,0.00010650929,0.000020544998,0.0001104276,0.98805887,0.000093751325,0.00010397058,0.006867129],"study_design_scores_gemma":[0.0008242279,0.025768155,0.070440955,0.00011138065,0.00026009293,0.00084295997,0.00024167931,0.0013855315,0.8926588,0.0003249076,0.007113164,0.000028060207],"about_ca_topic_score_codex":0.00022530912,"about_ca_topic_score_gemma":0.00046787228,"teacher_disagreement_score":0.0016228541,"about_ca_system_score_codex":0.00017359114,"about_ca_system_score_gemma":0.00016755318,"threshold_uncertainty_score":0.00542897},"labels":[],"label_agreement":null},{"id":"W4252246510","doi":"10.33393/dti.2008.1333","title":"Therapies to Increase ApoA-I and HDL-Cholesterol Levels","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Medicine; Cholesterol; Ldl cholesterol; Internal medicine; Bioinformatics; Intensive care medicine; Biology","score_opus":0.019949095845854983,"score_gpt":0.2353904733805925,"score_spread":0.21544137753473752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252246510","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34956127,0.2508309,0.019642767,0.055042036,0.007228367,0.0008450411,0.006401134,0.0023256934,0.30812278],"genre_scores_gemma":[0.84495056,0.050518792,0.0075335074,0.018469041,0.005234677,0.0004130859,0.0030823566,0.00013596998,0.069662064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996723,0.00008967739,0.000035514586,0.00003865708,0.00012300634,0.000040831063],"domain_scores_gemma":[0.9993418,0.00029294763,0.00010459516,0.00008012861,0.0000866825,0.00009379265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046624016,0.00040502264,0.00075060606,0.0007038483,0.00022145144,0.0007924723,0.0003704913,0.0007101708,0.020369496],"category_scores_gemma":[0.0014766285,0.00012382692,0.00047147626,0.00035611697,0.00032399633,0.00039479948,0.0003960625,0.0020033524,0.005986087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007579041,0.0026307371,0.008034861,0.0017962649,0.0005025918,0.0020012353,0.00013447792,0.0002688831,0.058798254,0.0078007667,0.038956884,0.87149596],"study_design_scores_gemma":[0.012744644,0.022819236,0.08759179,0.002098632,0.0018486446,0.014383336,0.00058670604,0.0023650827,0.08256532,0.019888327,0.75300115,0.00010708112],"about_ca_topic_score_codex":0.00034225316,"about_ca_topic_score_gemma":0.0007491369,"teacher_disagreement_score":0.020369496,"about_ca_system_score_codex":0.00029931054,"about_ca_system_score_gemma":0.00046559147,"threshold_uncertainty_score":0.06814277},"labels":[],"label_agreement":null},{"id":"W4361197222","doi":"10.33393/dti.2008.1332","title":"Recent Advancements in Targeted Delivery of Therapeutic Molecules in Neurodegenerative Disease–-Spinocerebellar Ataxia–-Opportunities and Challenges","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Faculty of Medicine, McGill University; McGill University","keywords":"Medicine; Spinocerebellar ataxia; Disease; Neuroscience; Bioinformatics; Intensive care medicine; Pathology; Psychology; Biology","score_opus":0.048467719500114276,"score_gpt":0.2384463568752153,"score_spread":0.189978637375101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361197222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051893372,0.8811723,0.024419585,0.027236138,0.00157801,0.000084247695,0.00030114033,0.0002397763,0.013075441],"genre_scores_gemma":[0.1962661,0.7653907,0.016268136,0.005412494,0.0034036408,0.00014765773,0.0005770216,0.000083329374,0.012450909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958736,0.00009680166,0.000052380987,0.00007261153,0.00011171925,0.000078986726],"domain_scores_gemma":[0.9988218,0.0006263886,0.00012035088,0.00006285554,0.00024179404,0.00012676843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030719363,0.00041015257,0.00088718894,0.0005267655,0.00043030066,0.002323743,0.0006174213,0.0009974773,0.0066891243],"category_scores_gemma":[0.0013312788,0.00022884985,0.00038219918,0.0006008704,0.0010373697,0.0030773762,0.0010433323,0.001827001,0.0018277612],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015992015,0.00049285305,0.0018605809,0.0049216915,0.000081466795,0.0005880177,0.00046642052,0.0019262247,0.14855601,0.037483387,0.016455652,0.78556854],"study_design_scores_gemma":[0.00028283053,0.002835792,0.005764017,0.0010935157,0.00027448044,0.0036665583,0.0012446911,0.005522749,0.1750714,0.023007037,0.7811504,0.00008649563],"about_ca_topic_score_codex":0.00042045597,"about_ca_topic_score_gemma":0.00096866925,"teacher_disagreement_score":0.0066891243,"about_ca_system_score_codex":0.0006792814,"about_ca_system_score_gemma":0.0009610366,"threshold_uncertainty_score":0.022377372},"labels":[],"label_agreement":null},{"id":"W4385283736","doi":"10.33393/dti.2012.1373","title":"Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent","year":2012,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Resveratrol; Medicine; Inflammation; Matrix metalloproteinase; Bioinformatics; Carcinogen; Cancer research; Pharmacology; Neuroscience; Internal medicine; Biology; Genetics","score_opus":0.0077311540817577235,"score_gpt":0.22626720317475676,"score_spread":0.21853604909299904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385283736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610984,0.009488196,0.014787668,0.0012846212,0.0003859119,0.00008032237,0.0009614049,0.00053241214,0.011381113],"genre_scores_gemma":[0.9848038,0.0020473117,0.001665337,0.00021716951,0.000045302753,0.00002789497,0.0006554819,0.00004276847,0.010494929],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998354,0.00002545538,0.000009162582,0.00004257822,0.000051761752,0.000035689885],"domain_scores_gemma":[0.9998846,0.000016032653,0.00003011557,0.00002273971,0.000023546881,0.000022833457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016165798,0.0003604957,0.0002852592,0.00023082101,0.00015688194,0.0003514909,0.00022466277,0.0003426998,0.0039086253],"category_scores_gemma":[0.00015115936,0.0002173545,0.0005329707,0.00008062501,0.0003071744,0.00032053105,0.00020780679,0.0008024337,0.0009073543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033683545,0.00004685164,0.0001624525,0.00006498617,0.00001930534,0.000041749234,0.000012809991,0.00004231232,0.99613035,0.0004312635,0.00013422509,0.0025767926],"study_design_scores_gemma":[0.000051580228,0.00066680333,0.008047427,0.000013255415,0.00006449804,0.00022580058,0.000050909384,0.00067113934,0.9838972,0.00027860375,0.0060248645,0.000007895704],"about_ca_topic_score_codex":0.00045741792,"about_ca_topic_score_gemma":0.0014109141,"teacher_disagreement_score":0.0039086253,"about_ca_system_score_codex":0.00025035118,"about_ca_system_score_gemma":0.00026298294,"threshold_uncertainty_score":0.013075709},"labels":[],"label_agreement":null},{"id":"W4385284415","doi":"10.33393/dti.2009.1337","title":"A Model for NAD(P)H:Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy","year":2009,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation; Welch Foundation","keywords":"Medicine; Chemotherapy; Cancer imaging; Cancer chemotherapy; Oncology; NAD+ kinase; Cancer; Internal medicine; Medical physics; Bioinformatics; Cancer research; Biology; Biochemistry; Enzyme","score_opus":0.1214002722564105,"score_gpt":0.42995407238189937,"score_spread":0.3085538001254889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385284415","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12912555,0.0019384568,0.6692079,0.021055719,0.0011938846,0.00019169658,0.0012018516,0.00043797508,0.17564704],"genre_scores_gemma":[0.8795427,0.0013580581,0.04455127,0.0009613287,0.00026506544,0.00023245833,0.00032287437,0.00014915023,0.072616965],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998865,0.00003287949,0.000004639766,0.000027906483,0.000027605283,0.000020411855],"domain_scores_gemma":[0.9998678,0.000040424125,0.000021499249,0.000013442575,0.000027017866,0.000029839644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024324653,0.00037135588,0.00064758584,0.00040590912,0.0006909213,0.0010602772,0.0015884489,0.0013165848,0.011478105],"category_scores_gemma":[0.0006060621,0.00018599862,0.00071865035,0.00033332518,0.0008826199,0.0016374008,0.0009686923,0.0008879259,0.0016200143],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050206807,0.000050446448,0.00033066445,0.0000928354,0.000022970507,0.0002597745,0.00012123629,0.16304687,0.005320628,0.8191611,0.004537075,0.0070061707],"study_design_scores_gemma":[0.00004421357,0.000058990485,0.0001586408,0.00001570833,0.000017875263,0.00009554303,0.00006554245,0.65303004,0.00055260933,0.33650884,0.009430969,0.000020993104],"about_ca_topic_score_codex":0.0035766265,"about_ca_topic_score_gemma":0.0030960303,"teacher_disagreement_score":0.011478105,"about_ca_system_score_codex":0.0010912343,"about_ca_system_score_gemma":0.0008784563,"threshold_uncertainty_score":0.038398087},"labels":[],"label_agreement":null},{"id":"W4385439599","doi":"10.33393/dti.2013.1346","title":"Impact of Hepatocyte Growth Factor on Skeletal Myoblast Transplantation Late After Myocardial Infarction","year":2013,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Greenfield Research (Canada); Dalhousie University","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Hepatocyte growth factor; Myocardial infarction; Transplantation; Skeletal muscle; Growth factor; Myocyte; Infarction; Cardiology; Internal medicine; Pathology","score_opus":0.006742084129002327,"score_gpt":0.24695662901004678,"score_spread":0.24021454488104446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385439599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846674,0.009067876,0.00036879428,0.001208401,0.00031762174,0.000045097862,0.00030761593,0.000045538298,0.0039717243],"genre_scores_gemma":[0.9931902,0.002733175,0.0002632368,0.00039611344,0.0003190154,0.0000320652,0.00053194695,0.000008442735,0.0025258916],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998394,0.000040836952,0.000011778979,0.000015069625,0.000031083386,0.00006168484],"domain_scores_gemma":[0.9996506,0.00008305543,0.0000755715,0.000034934794,0.000034040208,0.00012175384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041419684,0.0001962238,0.0006130204,0.0001830265,0.00020005678,0.0005683074,0.00021840089,0.00036172624,0.004069589],"category_scores_gemma":[0.0005536729,0.00004450604,0.00049980177,0.00020643881,0.00030597489,0.00023624008,0.000267416,0.0009534918,0.00044057413],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17908199,0.014249164,0.042942148,0.0009942909,0.001005036,0.0026379537,0.00015077574,0.0010316602,0.29114208,0.001485345,0.0065077664,0.45877182],"study_design_scores_gemma":[0.011634944,0.2199454,0.58125097,0.00065861864,0.0032609697,0.0032085427,0.0010909045,0.002228056,0.15217105,0.0017907502,0.022674786,0.00008504967],"about_ca_topic_score_codex":0.00047909582,"about_ca_topic_score_gemma":0.0015842671,"teacher_disagreement_score":0.004069589,"about_ca_system_score_codex":0.00025812304,"about_ca_system_score_gemma":0.0005870151,"threshold_uncertainty_score":0.013614178},"labels":[],"label_agreement":null}]}